Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Increased
Reduced
Net increased
Funds Holding
4,346
Funds Holding Change
+39
Funds Holding Growth
+0.9%
Value
$1.42T
Holding in Top 10
987
Top 10 Change
-78
Top 10 Growth
-7%
Value Growth
+4%
New
168
Increased
2,123
Reduced
1,852
Closed
75
Capital Inflow
$49.9B
Capital Outflow
$32.9B
Net Capital Flow
+$16.9B
Capital Flow Change
+$2.13B
Calls
$19.1B
Puts
$17.5B
Net Calls
+$1.59B
Put/Call Ratio
0.92